Administration of Heparin by Continuous Intravenous Infusion in the Treatment of Deep Venous Thrombosis

Abstract

In this prospective study the authors compared two approaches to heparin therapy, in the treatment of deep venous thrombosis—continuous infusion heparin and intermittent heparin therapy.

Each group was comparable with respect to age, gender, risk factors, and etiologic factors. The continuous infusion group (n=60) received a heparin bolus of 150 U/kg followed by continuous intravenous infusion of 750 U/kg/twenty-four hours. The intermittent group (n=60) received a bolus of 5000 U in every four hour period. In the infusion therapy group, the resolution of clinical symptoms was more rapid, so the hospitalization time was shorter, and the hemorrhagic complications and relapses were fewer than with intermittent therapy.

The authors conclude that administration of heparin by continuous infusion appears to be effective and safer than intermittent injection therapy.

Get full access to this article

View all access options for this article.

References

Kakkar W. : Pathophysiologic characteristics of venous thrombosis. Am J Surg 150(4A):1-6, 1985.

Tsapogas MJ : Venous thrombosis. Alabama J Med Sci 24:176-182, 1987.

Andriuoli G. ,. Mastacchi R. : Comparison of the antithrombotic and haemorrhagic effects of heparin. Haemostasis 15:3224-3230, 1985

Dorfman GS , Cronan JJ , Tupper TB , et al: Occult Pulmonary Embolism: A common occurrence in deep venous thrombosis. AJR 148:263-266, 1987.

Holm HA , Kalvenes S. , Abildgaard U. : Changes in plasma antithrombin heparin cofactor activity during intravenous heparin therapy. Scand J Haematol 35:564-569, 1985.

Holm HA , Abildgaard U. , Kalvenes S. , et al: The antithrombotic effect of heparin in deep venous thrombosis: Relation to four heparin assays. Acta Med Scand 216:287-293, 1984.

Almazan A. , Lozano F. , Ramos M. , et al: Laboratory control of continuous intravenous heparin therapy with Howel time and activated partial thromboplastin time. Angiology 36:363-369, 1985.

Conti S. , Daschbach M. , Blaisdell W. : A comparison of high-dose versus conventional-dose heparin therapy for deep venous thrombosis. Surgery 92:972-980, 1982.

Salzman EW , Deykin D. , Shapiro RM , et al: Management of heparin therapy. N Engl J Med 15:1046-1050, 1975.

10.

Babcock RB , Dumper CW , Scharfman WB : Heparin-induced immune thrombocytopenia. N Engl J Med 295:237-241, 1976.

11.

Glazier RL , Crowell EB : Randomized prospective trial of continuous vs. intermittent heparin therapy . JAMA 236:1365-1367, 1976 .

12.

White MT , Bernene JL , Marino AM : Continuous heparin infusion requirements. JAMA 241:2717-2720,1979.

13.

Bounemeaux H. : Deep venous thrombosis: An overview. VASA Suppl 25, 1988.

14.

Doyle DJ , Turpie Agg , Hirsh J. , et al: Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep venous thrombosis. Ann Int Med 107:441-445, 1987.

15.

Walker MG , Shaw JW , Thomson Gjl , et al: Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep venous thrombosis of the legs: A multicentre prospective randomized trial. Br Med J 294:1189-1191, 1987.

16.

Seiden AM , Pensak ML : Postoperative deep venous thrombosis and pulmonary embolism: diagnosis, management and prevention. Am J Otol 7:377-383, 1986.

17.

Hull RD , Raskab GE , Hirsh J. , et al: Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 315:1109-1115, 1986.

18.

Coon WW : Anticoagulant therapy. Am J Surg 150:45-49, 1985.

19.

Benchekroun S. , Eychenne B. , Mericq O. , et al: Heparin half-life and sensitivity in normal subjects and in patients affected by deep vein thrombosis . Eur J Clin Invest 16:536-539, 1986.